Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
November 4, 2019
Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy
Bruno Emond, Murali Sundaram, Hela Romdhani, et al.
Genetic Epidemiology
|
January 6, 2015
Pathway-based association study of multiple candidate genes and multiple traits using structural equation models
Hela Romdhani, Heungsun Hwang, Gilles Paradis, et al.
Current Medical Research and Opinion
|
April 14, 2018
Economic burden of treatment failure in chronic lymphocytic leukemia patients
Song Wang, Marie-Hélène Lafeuille, Patrick Lefebvre, et al.
Journal of Drug Assessment
|
December 30, 2022
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews
Babafemi O Taiwo, Hela Romdhani, Marie-Hélène Lafeuille, et al.
Pharmacoeconomics - Open
|
August 4, 2023
Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn's Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases
Chitra Karki, Dominick Latremouille-Viau, Inmaculada Gilaberte, et al.
Journal of Medical Economics
|
May 13, 2025
Non-optimal treatment with first tyrosine kinase inhibitor and associated economic burden in chronic myeloid leukemia
Vamsi Kota, David Wei, Daisy Yang, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 21, 2025
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis
Maral DerSarkissian, Chelsea Norregaard, Hela Romdhani, et al.
Drugs - Real World Outcomes
|
February 10, 2021
Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study
Lucio Gordan, Melody Chang, Marie-Hélène Lafeuille, et al.
Future Oncology (London, England)
|
April 7, 2025
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US
Jason Hafron, Agnes Hong, Michael J Ryan, et al.
Pulmonary Therapy
|
May 17, 2026
Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19
Christian A Merlo, Hela Romdhani, Maral DerSarkissian, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Clinical Lymphoma, Myeloma & Leukemia
|
November 4, 2019
Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy
Bruno Emond, Murali Sundaram, Hela Romdhani, et al.
Genetic Epidemiology
|
January 6, 2015
Pathway-based association study of multiple candidate genes and multiple traits using structural equation models
Hela Romdhani, Heungsun Hwang, Gilles Paradis, et al.
Current Medical Research and Opinion
|
April 14, 2018
Economic burden of treatment failure in chronic lymphocytic leukemia patients
Song Wang, Marie-Hélène Lafeuille, Patrick Lefebvre, et al.
Journal of Drug Assessment
|
December 30, 2022
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews
Babafemi O Taiwo, Hela Romdhani, Marie-Hélène Lafeuille, et al.
Pharmacoeconomics - Open
|
August 4, 2023
Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn's Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases
Chitra Karki, Dominick Latremouille-Viau, Inmaculada Gilaberte, et al.
Journal of Medical Economics
|
May 13, 2025
Non-optimal treatment with first tyrosine kinase inhibitor and associated economic burden in chronic myeloid leukemia
Vamsi Kota, David Wei, Daisy Yang, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 21, 2025
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis
Maral DerSarkissian, Chelsea Norregaard, Hela Romdhani, et al.
Drugs - Real World Outcomes
|
February 10, 2021
Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study
Lucio Gordan, Melody Chang, Marie-Hélène Lafeuille, et al.
Future Oncology (London, England)
|
April 7, 2025
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US
Jason Hafron, Agnes Hong, Michael J Ryan, et al.
Pulmonary Therapy
|
May 17, 2026
Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19
Christian A Merlo, Hela Romdhani, Maral DerSarkissian, et al.
Page
of 3